Reichard CA - Search Results

1

Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.

Ranasinghe W, Shapiro DD, Hwang H, Wang X, Reichard CA, Elsheshtawi M, Achim MF, Bathala T, Tang C, Aparicio A, Tu SM, Navone N, Thompson TC, Pisters L, Troncoso P, Davis JW, Chapin BF. Ranasinghe W, et al. Among authors: reichard ca. Eur Urol. 2021 Feb;79(2):298-306. doi: 10.1016/j.eururo.2020.11.015. Epub 2020 Dec 3. Eur Urol. 2021. PMID: 33279304

2

Local Therapy for Disseminated Prostate Cancer: Improved Outcomes or Biased Confounders?

Reichard CA, Chapin BF. Reichard CA, et al. Eur Urol. 2017 Sep;72(3):352-353. doi: 10.1016/j.eururo.2017.05.014. Epub 2017 May 25. Eur Urol. 2017. PMID: 28552614 No abstract available.

3

Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes.

Reichard CA, Gregg JR, Achim MF, Aparicio AM, Pettaway CA, Pisters LL, Ward JF, Davis JW, Chapin BF. Reichard CA, et al. Eur Urol. 2018 Aug;74(2):140-143. doi: 10.1016/j.eururo.2018.03.031. Epub 2018 Apr 12. Eur Urol. 2018. PMID: 29656854

4

Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?

Reichard CA, Nyame YA, Sundi D, Tosoian J, Wilkins L, Alam R, Achim MF, Wang X, Stephenson AJ, Klein EA, Ross AE, Davis JW, Chapin BF. Reichard CA, et al. BJU Int. 2019 Aug;124(2):282-289. doi: 10.1111/bju.14671. Epub 2019 Feb 10. BJU Int. 2019. PMID: 30653804

5

Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment.

Reichard CA, Hoffman KE, Tang C, Williams SB, Allen PK, Achim MF, Kuban DA, Chapin BF. Reichard CA, et al. BJU Int. 2019 Nov;124(5):811-819. doi: 10.1111/bju.14780. Epub 2019 May 29. BJU Int. 2019. PMID: 31009137

6

Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design.

Reichard CA, Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF. Reichard CA, et al. Eur Urol Focus. 2021 Jan;7(1):71-77. doi: 10.1016/j.euf.2019.04.016. Epub 2019 May 8. Eur Urol Focus. 2021. PMID: 31076357

7

Treatment of the Primary Tumor in Metastatic Hormone-sensitive Prostate Cancer: Not Yet Ready for Prime Time as the Standard of Care.

Ranasinghe WKB, Reichard CA, Chapin BF. Ranasinghe WKB, et al. Among authors: reichard ca. Eur Urol. 2019 Nov;76(5):543-545. doi: 10.1016/j.eururo.2019.06.014. Epub 2019 Jun 25. Eur Urol. 2019. PMID: 31248604 Free PMC article.

8

Management of cT4 Prostate Cancer.

Ranasinghe WKB, Reichard CA, Bathala T, Chapin BF. Ranasinghe WKB, et al. Among authors: reichard ca. Eur Urol Focus. 2020 Mar 15;6(2):221-226. doi: 10.1016/j.euf.2019.06.012. Epub 2019 Jun 30. Eur Urol Focus. 2020. PMID: 31266732 Review.

9

Editorial Comment.

Reichard CA, Chapin BF. Reichard CA, et al. Urology. 2019 Sep;131:174. doi: 10.1016/j.urology.2019.03.041. Urology. 2019. PMID: 31451157 No abstract available.

10

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.

Ranasinghe W, Reichard CA, Nyame YA, Sundi D, Tosoian JJ, Wilkins L, Alam R, Achim MF, Wang X, Stephenson AJ, Klein EA, Ross AE, Allaf ME, Davis JW, Chapin BF. Ranasinghe W, et al. Among authors: reichard ca. J Urol. 2020 Oct;204(4):748-753. doi: 10.1097/JU.0000000000001074. Epub 2020 Apr 7. J Urol. 2020. PMID: 32259468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters